Aprepitant (Emend)
Also known as Emend
Aprepitant (Emend (US, EU)) is an antiemetic chemical compound that belongs to a class of drugs called substance P antagonists (SPA). It mediates its effect by blocking the neurokinin 1 (NK1) receptor.
Source: WikipediaEstimated Total Cost: $183.66 for an average of 7 days supply
What is it prescribed for?
Patients are most commonly prescribed aprepitant to treat breast cancer, metastatic cancer, lung cancer, and colorectal cancer.
What drug interactions are known?
Do not take aprepitant if you are taking any of the following:
Critical Interactions
Significant Interactions
Loading...